Juan González‐García
Universidad Veracruzana(MX)Hospital Universitario La Paz(ES)Instituto de Salud Carlos III(ES)Hospital de Basurto(ES)Hospital La Paz Institute for Health Research(ES)Centro de Investigación Biomédica en Red(ES)
Publications by Year
Research Areas
Hepatitis C virus research, HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV Research and Treatment, Liver Disease Diagnosis and Treatment
Most-Cited Works
- → Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected Patients(2004)1,234 cited
- → Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial(2017)498 cited
- → Sustained virological response to interferon plus ribavirin reduces liver‐related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus†(2009)295 cited
- → Severe Nucleoside-Associated Lactic Acidosis in Human Immunodeficiency Virus–Infected Patients: Report of 12 Cases and Review of the Literature(2002)181 cited
- → Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study(2021)169 cited
- → Sustained Virological Response to Interferon Plus Ribavirin Reduces Non-Liver-Related Mortality in Patients Coinfected With HIV and Hepatitis C Virus